You are here:
NICE
NICE Guidance
Conditions and diseases
Neurological conditions
Headaches
Fremanezumab for preventing migraine
Technology appraisal guidance
Reference number:
TA631
Published:
03 June 2020
This guidance has been updated and replaced by
NICE technology appraisal guidance 764
.